BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Zhang X, Jiang LP, Yin Y, Wang YD. XRCC1 and XPD genetic polymorphisms and clinical outcomes of gastric cancer patients treated with oxaliplatin-based chemotherapy: a meta-analysis. Tumour Biol 2014;35:5637-45. [PMID: 24590266 DOI: 10.1007/s13277-014-1746-y] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 0.8] [Reference Citation Analysis]
Number Citing Articles
1 Samavarchi Tehrani S, Esmaeili F, Shirzad M, Goodarzi G, Yousefi T, Maniati M, Taheri-Anganeh M, Anushiravani A. The critical role of circular RNAs in drug resistance in gastrointestinal cancers. Med Oncol 2023;40:116. [PMID: 36917431 DOI: 10.1007/s12032-023-01980-4] [Reference Citation Analysis]
2 Li T, Mizrahi D, Goldstein D, Kiernan MC, Park SB. Chemotherapy and peripheral neuropathy. Neurol Sci 2021;42:4109-21. [PMID: 34436727 DOI: 10.1007/s10072-021-05576-6] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
3 Marin JJG, Perez-Silva L, Macias RIR, Asensio M, Peleteiro-Vigil A, Sanchez-Martin A, Cives-Losada C, Sanchon-Sanchez P, Sanchez De Blas B, Herraez E, Briz O, Lozano E. Molecular Bases of Mechanisms Accounting for Drug Resistance in Gastric Adenocarcinoma. Cancers (Basel) 2020;12:E2116. [PMID: 32751679 DOI: 10.3390/cancers12082116] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 6.0] [Reference Citation Analysis]
4 Li M, Zhao Y, Zhao E, Wang K, Lu W, Yuan L. Predictive Value of Two Polymorphisms of ERCC2, rs13181 and rs1799793, in Clinical Outcomes of Chemotherapy in Gastric Cancer Patients: A Meta-Analysis. Dis Markers 2018;2018:3947626. [PMID: 30581498 DOI: 10.1155/2018/3947626] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
5 Santonocito C, Scapaticci M, Nedovic B, Annicchiarico EB, Guarino D, Leoncini E, Boccia S, Gasbarrini A, Capoluongo E. XRCC1 Arg399Gln Gene Polymorphism and Hepatocellular Carcinoma Risk in the Italian Population. Int J Biol Markers 2017;32:190-4. [DOI: 10.5301/jbm.5000241] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.3] [Reference Citation Analysis]
6 Ding C, Zhang H, Chen K, Zhao C, Gao J. Genetic variability of DNA repair mechanisms influences treatment outcome of gastric cancer. Oncol Lett 2015;10:1997-2002. [PMID: 26622786 DOI: 10.3892/ol.2015.3510] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 0.6] [Reference Citation Analysis]
7 Avan A, Postma TJ, Ceresa C, Avan A, Cavaletti G, Giovannetti E, Peters GJ. Platinum-induced neurotoxicity and preventive strategies: past, present, and future. Oncologist 2015;20:411-32. [PMID: 25765877 DOI: 10.1634/theoncologist.2014-0044] [Cited by in Crossref: 152] [Cited by in F6Publishing: 161] [Article Influence: 19.0] [Reference Citation Analysis]